Activated microglial cells play an important role in immune and inflammatory responses in CNS and play a role in neurodegenerative diseases. We examined the effects of lipoic acid (LA) on inflammatory responses of BV-2 microglial cells activated by lipopolysaccharide (LPS), and explored the underlying mechanisms of action of LA. BV-2 cells treated with LPS showed an up-regulation of mRNA of the pro-inflammatory molecules, inducible nitric oxide synthase (iNOS). LA suppressed the expression of iNOS and furthermore, LPS-induced production of nitrite. Moreover, LA suppressed the nuclear translocation of RelA, a component of nuclear factor-kappa B (NF-B) that contains transcriptional activator domain for LPS. The mechanisms of LA-mediated anti-inflammatory effects on microglia remain unknown, and we suggested an involvement of Akt/glycogen synthase kinase-3␤ (GSK-3␤) phosphorylation. The results showed that inhibitor of phosphatidylinositol 3-kinase prevented LA-mediated suppression of LPS induction of RelA and expression of iNOS. Furthermore, these inflammatory actions were prevented by GSK-3␤ inhibitors. These data demonstrate a role for LA as a chemical modulator of inflammatory responses by microglia, and thus may be a therapeutic strategy for treating neurodegenerative diseases with an inflammatory component.
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Introduction
Microglial cells are important players in immune and inflammatory responses in the CNS (Nam et al., 2010) , and their activation is implicated in several chronic neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD) and brain ischemia (Kang et al., 2004) . Activated microglial cells promote neuronal injury via the production of pro-inflammatory molecules such as the cytokines, tumor necrosis factor (TNF) ␣ and interleukin (IL)-1␤, and other cytotoxic molecules, such as reactive oxygen species (ROS) (Dheen et al., 2007) . The overexpression of pro-inflammatory cytokines has emerged as an important determinant of the cytotoxicity associated with inflammation in neurodegenerative diseases (Jin et al., 2007) . Furthermore, excessive production of nitric oxide (NO) in activated glia, resulting from the production of inducible nitric oxide synthase (iNOS), is thought to play a role in neurodegenerative pathology. Therefore, promoting counter regulatory mechanisms is essential to avoid inflammation-mediated injury in the CNS (McCarty, 2006) , and would thus require therapeutic agents that possess anti-inflammatory actions, targeting over-activated microglia cells. Lipoic acid (LA) was identified as a cofactor for mitochondrial ␣-ketoacid dehydrogenases in mammals (Smith et al., 2004) . LA may easily cross the blood brain barrier because of its small molecular size (206 g/mol) and high water and lipid solubility (Goraca and Asłanowicz-Antkowiak, 2009) . A number of studies have reported on the beneficial effects of LA on various disorders, such as hypertension (Thirunavukkarasu et al., 2004) and diabetes mellitus (Kamenova, 2006) . Although the cellular and molecular mechanisms associated with the positive actions of LA are partially understood for these diseases, little is known about its mechanistic actions underlying anti-inflammatory responses through GSK-3␤, including its effect on activated microglia (Zhang et al., 2007) . Therefore, the present study aimed to investigate the effect of LA
